ArticleBMC pediatrics2026
Trajectories of growth and language development among children with congenital hypothyroidism concerning gender differences: Egyptian study.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite significant advancements in the early detection and treatment of congenital hypothyroidism (CH), a developmental and growth gap persists between affected children and their healthy peers. This study aims to assess some growth and developmental aspects among a sample of Egyptian children who had CH and were subjected to the recommended national CH treatment program, with a focus on age- and gender-related differences.
methodsA prospective case-control follow-up study was conducted from February 2021 to February 2023 in Giza Governorate, Egypt, involving 80 children aged 1.5–3 years, including 40 with CH (Group A) and 40 age- and gender-matched healthy controls (Group B). CH was diagnosed at birth via newborn screening and confirmed by elevated TSH and low free T4 levels. Participants underwent two follow-up assessments: the first one year after initiation of thyroid hormone therapy and confirmation of treatment adherence, and the second one year later. During each follow-up, clinical, laboratory, growth, and developmental evaluations were conducted using CDC growth charts, PLS-4 (Arabic Version), Stanford-Binet 5th Edition, and Portage Program Questionnaire.
resultsBy the second follow-up, children with CH showed significant delays across all developmental domains compared to controls (p ≤ 0.001). Female children with CH exhibited earlier language delays—both receptive (p = 0.025) and expressive (p = 0.015)—during the first follow-up. In the second follow-up, girls continued to show deficits in height, weight, and receptive language age, although expressive language showed signs of improvement. Male children demonstrated more pronounced growth and developmental compromise during the second follow-up, with significant deficits in height (p = 0.001), weight (p = 0.016), and receptive language age (p = 0.001). An inverse correlation was observed between receptive language age and CH status.
conclusionsChildren with CH continue to face developmental and growth challenges despite adherence to standard treatment protocols. Delays appear earlier in girls, particularly in language domains, whereas boys tend to show more pronounced deficits with increasing age. These findings indicate a distinct gender-based developmental pattern in children with CH, emphasizing the importance of sex-specific monitoring and timely interventions to optimize long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.